400 results on '"Ferrari, Giulio"'
Search Results
2. Correction: Managing the ocular surface after glaucoma filtration surgery: an orphan topic
3. Cell therapy in the cornea: The emerging role of microenvironment
4. Topical formulations of Aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration
5. Future directions in managing aniridia-associated keratopathy
6. Neurosensory abnormalities and stability of a mouse model of dry eye disease
7. TFOS Lifestyle: Impact of lifestyle challenges on the ocular surface
8. The two-faced effects of nerves and neuropeptides in corneal diseases
9. Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series
10. Corrigendum to “TFOS lifestyle: Impact of lifestyle challenges on the ocular surface” [Ocul Surf 28 (2023) 262–303]
11. Anterior segment involvement in vitreoretinal lymphoma: clinical manifestations, molecular findings and in vivo confocal microscopy.
12. Cell Therapy Using Ex Vivo Cultured Limbal Cells: CLET and Equivalent
13. Corrigendum to “Future directions in managing aniridia-associated keratopathy” [Surv Ophthalmol 68 (2023) 940–956]
14. Application of narrative medicine in adult Rasmussen’s encephalitis patients: learning from the storytelling
15. Vitamin D supplementation reduces systemic modulation of oxidative stress and collagen degradation in keratoconus patients
16. Corneal nerves and wound healing: No gain without pain
17. Basic mechanisms and clinical implications of ocular surface inflammation
18. Neuroinflammation: The missing link between pain and immunity
19. In vivo confocal microscopy of the cornea: State of the art and the potential of artificial intelligence
20. Modulating neuroinflammation to restore vision
21. Beauveria bassiana Keratitis: A Case Series and Review of Literature
22. Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome
23. Magnetic states in prismatic core multishell nanowires
24. Anterior segment involvement in vitreoretinal lymphoma: clinical manifestations, molecular findings and in vivo confocal microscopy
25. Topical fosaprepitant for the treatment of ocular pain and inflammation
26. Cylindrical Two-Dimensional Electron Gas in a Transverse Magnetic Field
27. Quantum mechanics on curved 2D systems with electric and magnetic fields
28. Safety and Efficacy of Corneal Cross-Linking in Patients Affected by Keratoconus: Long-Term Results
29. Neurosensory abnormalities and stability of a novel mouse model of dry eye disease
30. Future directions in managing aniridia-associated keratopathy
31. High Frequency Electrotherapy for the Treatment of Meibomian Gland Dysfunction
32. Vitamin D Supplementation Impacts Systemic Biomarkers of Collagen Degradation and Copper Metabolism in Patients With Keratoconus
33. Nerves, vessels and inflammation at the ocular surface
34. Nerves, substance P and ocular surface inflammation
35. Contralateral inflammatory effects on the trigeminal ganglion after unilateral corneal lesion
36. Evaluation of a Post-Operative Therapy Protocol after Epithelium-Off Corneal Cross-Linking in Patients Affected by Keratoconus
37. The NK-1 Receptor Signaling: Distribution and Functional Relevance in the Eye
38. Long term safety and efficacy of corneal cross-linking in patients affected by keratoconus
39. Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders
40. Corneal endothelial cell reduction and increased Neurokinin-1 receptor expression in a graft-versus-host disease preclinical model
41. Growth inhibition of formed corneal neovascularization following Fosaprepitant treatment
42. Short-Term Topical Bevacizumab in the Treatment of Stable Corneal Neovascularization
43. Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery
44. Corneal Neovascularization and the Utility of Topical VEGF Inhibition: Ranibizumab (Lucentis) Vs Bevacizumab (Avastin)
45. Substance P/neurokinin-1 receptor pathway blockade ameliorates limbal stem cell deficiency by modulating mTOR pathway and preventing cell senescence
46. Corrigendum to “Topical formulations of aprepitant are safe and effective in relieving pain and inflammation, and drive neural regeneration” [Ocul Surf 30 (2023) 92–103]
47. Targeting Amyloid-β in Glaucoma Treatment
48. Nutritional and Metabolic Imbalance in Keratoconus
49. Corneal and Epidermal Nerve Quantification in Chemotherapy Induced Peripheral Neuropathy
50. Immunity and pain in the eye: focus on the ocular surface
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.